Microtubule disruption stimulates DNA synthesis in bovine endothelial cells and potentiates cellular response to basic fibroblast growth factor
- PMID: 8362986
- PMCID: PMC1887204
Microtubule disruption stimulates DNA synthesis in bovine endothelial cells and potentiates cellular response to basic fibroblast growth factor
Abstract
Cultured endothelial cells characteristically form a monolayer and become quiescent at saturation density. This study shows that microtubule destabilization in confluent cultures of bovine aortic endothelial cells stimulates fibroblast growth factor 2 (FGF-2, bFGF)-dependent DNA synthesis. Twenty-four hours after addition of the microtubule-disrupting drug colchicine, tritiated thymidine incorporation increases up to fivefold when compared to control cultures. Significant stimulation is seen with doses from 0.05 to 1.0 microgram/ml. The effect of colchicine is quantitatively similar to stimulation of the same cultures with 5 ng/ml FGF-2. Furthermore, the stimulation of DNA synthesis by colchicine can be completely blocked by the addition of a neutralizing antibody to FGF-2. This suggests that colchicine may stimulate bovine aortic endothelial cells by modulating endogenous FGF-2/receptor interactions or that colchicine acts by a different mechanism that requires the growth factor for mitogenicity. The combined effects of colchicine and FGF-2 are more than additive, which supports the idea that microtubule disruption may facilitate cellular response to FGF-2. Cytochalasin B, preventing actin polymerization, inhibits the mitogenic response to FGF-2 but not the response to colchicine. These results are best interpreted as evidence that colchicine stimulates endothelial cell DNA synthesis by a pathway that requires endogenous FGF-2 and may be facilitating cellular responsiveness to the growth factor by disrupting the monolayer via the cytoskeleton.
Similar articles
-
Expression of fibroblast growth factor-5 by bovine choroidal endothelial cells in vitro.Invest Ophthalmol Vis Sci. 1997 Sep;38(10):2073-80. Invest Ophthalmol Vis Sci. 1997. PMID: 9331271
-
Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells.Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2326-34. Invest Ophthalmol Vis Sci. 1996. PMID: 8843917
-
TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).Kidney Int. 2001 Feb;59(2):579-92. doi: 10.1046/j.1523-1755.2001.059002579.x. Kidney Int. 2001. PMID: 11168939
-
Disruption of cytoskeletal structures mediates shear stress-induced endothelin-1 gene expression in cultured porcine aortic endothelial cells.J Clin Invest. 1993 Oct;92(4):1706-12. doi: 10.1172/JCI116757. J Clin Invest. 1993. PMID: 8408624 Free PMC article.
-
Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression.Circulation. 2000 Jan 18;101(2):171-7. doi: 10.1161/01.cir.101.2.171. Circulation. 2000. PMID: 10637205
Cited by
-
Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins.Antimicrob Agents Chemother. 1999 Oct;43(10):2528-33. doi: 10.1128/AAC.43.10.2528. Antimicrob Agents Chemother. 1999. PMID: 10508038 Free PMC article. Clinical Trial.
-
Comparison of basic fibroblast growth factor levels in clone A human colon cancer cells in vitro with levels in xenografted tumours.Br J Cancer. 1995 Jul;72(1):10-6. doi: 10.1038/bjc.1995.269. Br J Cancer. 1995. PMID: 7599036 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources